5 jobs found in watertown

FLEXIBLE SCHEDULE including 4 10-hour shifts and 5 8-hour shifts!* Here is your chance to showcase your skills with an established, yet growing, company that's been in business for over 25 years! RITALKA is a family-owned company that focuses on creating jobs in rural communities in the upper Midwest; purposefully deciding to create jobs away from the chaos of larger metro areas. Our company values help to foster strong relationships with not only our employees and customers, but also our communities. We take pride in finding careers that fit the person rather than a person to fit a job which allows us all to do extraordinary things with ordinary people. SALARY IN ACCORDANCE WITH APPLICABLE EXPERIENCE! BENEFITS Medical Insurance, Health Savings Plan (HSA), Flexible Spending Plans (Dependent and Medical), Accident Insurance, Critical Illness, Short-Term Disability, Long-Term Disability, 401(k) with an employer match, Term Life Benefits, Employee Assistance Program (EAP),...

Description: Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing novel, integrated drug and delivery solutions for the localized treatment of patients with chronic rhinosinusitis (CRS) and other chronic diseases. Lyra has two investigational product candidates, LYR-210 and LYR-220, in late-stage development for CRS, a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities. LYR-210 and LYR-220 are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and are intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages as an alternative to sinus surgery. LYR-210 is designed for surgically naïve patients and is being evaluated in the ENLIGHTEN Phase 3 clinical program, while LYR-220, an enlarged matrix, is being evaluated in patients who have recurrent symptoms despite surgery in the...

Job Summary Join our team and be a part of our mission to deliver accessible, high-quality, affordable, and compassionate healthcare. Prairie Lakes Healthcare System is an independent, non-profit healthcare system serving 10 counties in northeastern South Dakota and west-central Minnesota. Our team at Prairie Lakes makes a difference in the lives of patients and their loved ones. This Full Time position will plan, direct, coordinate and/or supervise the delivery of supply chain services provided by the Supply Chain department. Responsibilities include: Supervise the Supply Chain department staff by interviewing, selecting, training, assigning work and appraising performance and competencies to ensure that the department meets its goals and objectives. Act as a resource to department personnel and other hospital departments in matters such as purchasing procedures and product detail. Devise methods and policies ensuring the most efficient and economical movement of all materials in...

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing novel, integrated drug and delivery solutions for the localized treatment of patients with chronic rhinosinusitis (CRS) and other chronic diseases. Lyra has two investigational product candidates, LYR-210 and LYR-220, in late-stage development for CRS, a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities. LYR-210 and LYR-220 are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and are intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages as an alternative to sinus surgery. LYR-210 is designed for surgically naïve patients and is being evaluated in the ENLIGHTEN Phase 3 clinical program, while LYR-220, an enlarged matrix, is being evaluated in patients who have recurrent symptoms despite surgery in the BEACON Phase 2...

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing novel, integrated drug and delivery solutions for the localized treatment of patients with chronic rhinosinusitis (CRS) and other chronic diseases. Lyra has two investigational product candidates, LYR-210 and LYR-220, in late-stage development for CRS, a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities. LYR-210 and LYR-220 are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and are intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages as an alternative to sinus surgery. LYR-210 is designed for surgically naïve patients and is being evaluated in the ENLIGHTEN Phase 3 clinical program, while LYR-220, an enlarged matrix, is being evaluated in patients who have recurrent symptoms despite surgery in the BEACON Phase 2...